Moral hazard and the demand for physician services: First lessons from a French natural experiment

https://doi.org/10.1016/S0014-2921(98)00015-4Get rights and content

Abstract

This paper presents empirical results on moral hazard in demand for medical care, using a longitudinal dataset on 4578 individuals followed during two years. The dataset contains two subgroups, one for which a copayment rate of 10% for physician visits was introduced in 1994, and an other for which no change occurred during the period of the study. This enables us to use these data as coming from a controlled natural experiment. We test if the number of visits per agent was modified by this copayment rate. The data reject the hypothesis for office visits, but do not for home visits. This suggests that there is moral hazard in demand for some physician services, but also that when non-monetary costs are important, small changes in monetary price may not induce any major change in behavior

Introduction

The magnitude and growth rate of health expenditures have been a major concern for most developed economies during the last decades. A frequently encountered view is that excessive expenditures are a consequence of the existence of large-scale health insurance schemes, resulting in a divorce between the amount consumed by each agent and the cost she actually bears. According to this `moral hazard' explanation, a natural solution would be to impose deductibles (or copayments), in order to provide adequate incentives to cost reduction.

The potential benefits of such a policy have, however, been vividly debated. The key aspect of the discussion is, in essence, an empirical one: to what extent can the introduction of a deductible be expected to significantly reduce each agent's level of health expenditures? If moral hazard is an important feature of medical consumption, then not only deductible are socially acceptable, but they improve welfare. In the opposite case, however, imposing to everyone some minimum deductible is inefficient, because it reduces the scope of mutually beneficial insurance contracts without any gain in terms of aggregate risk.

A large literature has been devoted to the analysis of demand for medical care in general, and physician services in particuliar. In this paper, we contribute to this general line of research by analyzing the results of a French `natural experiment'. In 1993, public health insurance reduced its cost-sharing rates for most ambulatory services. Most French households, however, are, in addition, partly or fully covered by a supplementary, private insurance contract. Some of the firms providing these contracts decided to compensate for this reduction in public coverage by extending their guarantees and increasing the premium; others, on the contrary, seized this opportunity to redesign their contracts by introducing a copayment rate. We follow two samples of employees belonging to these two classes, and investigate the differences in reactions due to the reform.

The structure of the paper is as follows. In Section 2, we briefly review the conclusions of contract theory and the kind of tests they suggest. In Section 3, we present the French system of health insurance, and describe the characteristics of our dataset. In Section 4, we present some first results, and discuss these results in the last section.

Section snippets

The polar cases: Adverse selection and moral hazard

In principle, the literature on competition under adverse selection provides clear-cut predictions, that can be tested empirically. The literature on adverse selection in a competitive setting, as initiated by the seminal contributions of Akerlof (1970), Rothschild and Stiglitz (1976)and Wilson (1977), predicts several qualitative features that have revealed quite robust.1

The French system

Almost all French households are covered by a public insurance system (Assurance Maladie), which is based on mandatory participation and income-based premium. This public insurance covers an average of 74% of total health expenditures of households, but the cost sharing by social security varies from 55% for pharmaceutical goods to 58% for ambulatory care, to 92% for hospital inpatient care.

Average number of visits

The average number of visits per year and per individual, in each group and for each year (standard deviation between brackets), is given in Table 1.

As the numbers show, the average number of home and office visits for general practitioners is higher in the test group than in the control group. This can be due to the different age structure, or to difference in other, unobservable, characteristics, and subsequent analysis will attempt to answer this question.

Note that the numbers are consistent

Discussion

In terms of GP office visits or specialist visits, we cannot conclude from our analysis that the change in relative price had any influence on the participation decision. However, we find that the change in relative price had a moderating influence on the participation rate in GP home visits.

Previous studies have attempted to estimate the elasticity of demand for medical care in general, and for physician services in general. First, results from a (non-controlled) natural experiment suggested

Acknowledgements

We thank J. Pinquet, and seminar participants at NBER, Cambridge, and EEA Congress, Toulouse, for useful comments and suggestions. Financial support from the French federation of insurance companies (FFSA) is gratefully acknowledged. Errors are strictly ours.

References (16)

  • C Wilson

    A model of insurance markets with incomplete information

    Journal of Economic Theory

    (1977)
  • G Akerlof

    The market for lemons: quality uncertainty and the market mechanism

    Quarterly Journal of Economics

    (1970)
  • Arnott, R., Stiglitz, J., 1993. Price equilibrium, efficiency and decentralizability in insurance markets with moral...
  • Caussat, L., Glaude, M., 1993. Dépenses médicales et couverture sociale. Economie et...
  • Chiappori, P.A., Salanié, B., 1997a. Empirical contract theory: The case of insurance data. European Economic Review,...
  • Chiappori, P.A., Salanié, B., 1997b. Testing for asymmetric information on insurance markets. CREST...
  • Dionne, G., Gouriéroux, C., Vanasse, C., 1996. Evidence of adverse selection in automobile insurance markets....
  • Dionne, G., Gouriéroux, C., Vanasse, C., 1997. The informational content of household decisions, with an application to...
There are more references available in the full text version of this article.

Cited by (117)

  • Asymmetric information and insurance: An experimental approach

    2021, Journal of Behavioral and Experimental Economics
    Citation Excerpt :

    Finkelstein and Poterba (2004) assume the scope for moral hazard is limited in annuities and then test for adverse selection in that market; He (2009) uses similar reasoning to test for adverse selection in the life insurance market. Research on moral hazard utilizes exogenous policy changes to measure behavioral effects in health insurance markets (Chiappori, Durand, & Geoffard, 1998; Klick & Stratmann, 2007), auto insurance (Cohen & Dehejia, 2004), and workers compensation insurance (Bolduc et al., 2002; Kaestner and Carroll, 1997).4 Our methodology provides an alternative platform to detect the overall impact of asymmetric information, as well as further decompose these effects into moral hazard and adverse selection.

  • Medical insurance and free choice of physician shape patient overtreatment: A laboratory experiment

    2016, Journal of Economic Behavior and Organization
    Citation Excerpt :

    Most of these studies find that increased co-payment reduces the demand for medical services. Chiappori et al. (1998) provide a particularly convincing study on this matter. These authors analyze data from a natural experiment where a co-payment rate of 10% was introduced for one group of patients but not for a control group of patients.

View all citing articles on Scopus
View full text